Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Corcept Therapeutics Incorporated (CORT) had Receiveable Turnover of 12.51 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$675.04M |
|
$139.73M |
|
$10.88M |
|
$664.16M |
|
$538.09M |
|
$136.95M |
|
$24.54M |
|
$161.49M |
|
$161.49M |
|
$141.21M |
|
$141.21M |
|
$141.21M |
|
$141.21M |
|
$136.95M |
|
$127.35M |
|
103.23M |
|
113.48M |
|
$1.35 |
|
$1.23 |
|
| Balance Sheet Financials | |
$471.60M |
|
$2.69M |
|
$368.95M |
|
$840.55M |
|
$140.77M |
|
-- |
|
$20.19M |
|
$160.96M |
|
$679.59M |
|
$679.59M |
|
$679.59M |
|
105.11M |
|
| Cash Flow Statement Financials | |
$198.07M |
|
$-177.60M |
|
$-28.35M |
|
$135.55M |
|
$127.67M |
|
$-7.89M |
|
$61.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.39% |
|
20.29% |
|
20.29% |
|
18.87% |
|
23.92% |
|
20.70% |
|
$195.90M |
|
-- |
|
-- |
|
-- |
|
0.80 |
|
0.88 |
|
|
Receiveable Turnover |
12.51 |
29.19 |
|
20.78% |
|
20.78% |
|
16.80% |
|
20.78% |
|
$6.47 |
|
$1.73 |
|
$1.75 |
|